Opportunity Information: Apply for CDC RFA GH14 140103CONT16
Apply for CDC RFA GH14 140103CONT16
- The HHS-CDC in the health sector is offering a public funding opportunity titled "Protecting the Advances in Polio, Rubella and Measles Elimination: Strengthening Immunization Programs in the Americas." and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.185.
- This funding opportunity was created on Oct 28, 2015 and posted on Oct 28, 2015.
- Applicants must submit their applications by Dec 29, 2015. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
Protecting the Advances in Polio, Rubella and Measles Elimination: Strengthening Immunization Programs in the Americas is a continuation funding opportunity from the U.S. Department of Health and Human Services, Centers for Disease Control and Prevention (HHS-CDC). It is issued as a cooperative agreement, which typically means CDC expects to have substantial involvement in the work beyond simply providing funds, such as collaborating on planning, technical guidance, monitoring, and performance evaluation. The program is positioned within the health activity category and is associated with CFDA number 93.185, indicating it falls under CDC global health or immunization related assistance.
The purpose of the opportunity, as indicated by the title and description, is to safeguard and sustain hard-won regional achievements in eliminating or controlling polio, rubella, and measles across the Americas by strengthening routine immunization systems and the broader program capacities that keep these diseases from resurging. In practical terms, opportunities like this generally focus on reinforcing the building blocks that prevent outbreaks: maintaining high vaccination coverage, improving the quality and reach of immunization services, ensuring strong disease surveillance and rapid outbreak response, and addressing operational gaps that can lead to immunity gaps in specific communities. The emphasis on "protecting advances" signals a priority on sustaining elimination status and preventing reintroduction or reestablishment of transmission, which requires continuous system performance even after incidence has been reduced.
This announcement is identified as a continuation (OpportunityCategory: Continuation), meaning it is intended to extend or build on an existing CDC-funded effort rather than launching a brand-new competitive program. The funding opportunity number is CDC RFA GH14 140103CONT16. It was created and posted on October 28, 2015, with an original and current closing date of December 29, 2015, which places it in a defined application window for that continuation action. The listing notes an award ceiling of 0 and does not specify the expected number of awards in the provided data, which can happen in continuation notices when funding levels are determined by existing cooperative agreement terms, prior year funding, negotiated work plans, or the availability of appropriations, rather than a stated maximum for new applicants.
Eligibility is listed as "Others," with a reference to consult an "Additional Information on Eligibility" section for the precise clarification. That phrasing is commonly used when eligibility is limited to specific entities such as an existing award recipient, a narrow set of organizations with a particular role, or partners meeting specific criteria not captured by standard categories (for example, certain nonprofit organizations, international organizations, or entities already engaged in a defined immunization partnership). Because the provided source excerpt does not include the full eligibility clarification text, the safest interpretation is that eligibility is restricted and not broadly open to all applicant types, which aligns with the continuation nature of the funding.
Overall, the opportunity is best understood as a CDC-supported effort to help countries or regional partners in the Americas maintain elimination gains against polio, rubella, and measles by strengthening immunization program performance and the supporting public health infrastructure. In continuation form, it likely supports ongoing activities such as improving immunization planning and management, enhancing data quality and use for coverage monitoring, strengthening vaccine-preventable disease surveillance, training and capacity building, and sustaining the readiness needed to rapidly detect and respond to suspected cases or outbreaks so that elimination achievements are not reversed.
Frequently Asked Questions (FAQs)
What is the name of this funding opportunity?
The opportunity is titled Protecting the Advances in Polio, Rubella and Measles Elimination: Strengthening Immunization Programs in the Americas.
Which federal agency is offering this opportunity?
This is offered by the U.S. Department of Health and Human Services (HHS), specifically the Centers for Disease Control and Prevention (CDC).
What type of funding mechanism is this?
It is a cooperative agreement. This typically means CDC expects to be substantially involved in the work beyond providing funds, such as collaborating on planning, providing technical guidance, monitoring progress, and participating in performance evaluation.
What does CDC involvement usually look like in a cooperative agreement?
Based on how the opportunity describes a cooperative agreement, CDC involvement can include collaboration on planning, technical guidance, monitoring, and performance evaluation rather than a hands-off grant relationship.
What is the main purpose of this opportunity?
The purpose is to protect and sustain elimination or control achievements for polio, rubella, and measles across the Americas by strengthening routine immunization systems and broader program capacities that prevent these diseases from resurging.
Which diseases does this opportunity focus on?
The opportunity focuses on polio, rubella, and measles.
What geographic region is emphasized?
The emphasis is on strengthening immunization programs in the Americas.
What does "protecting advances" mean in this context?
It signals a priority on sustaining elimination status and preventing reintroduction or reestablishment of transmission, which requires ongoing performance of immunization and public health systems even after disease incidence has been reduced.
What kinds of activities are generally supported under an opportunity like this?
Based on the description provided, activities generally align with strengthening the building blocks that prevent outbreaks, such as:
- Maintaining high vaccination coverage
- Improving the quality and reach of immunization services
- Strengthening disease surveillance and rapid outbreak response
- Addressing operational gaps that can create immunity gaps in specific communities
- Improving immunization planning and management
- Enhancing data quality and the use of data for coverage monitoring
- Training and capacity building
- Sustaining readiness to rapidly detect and respond to suspected cases or outbreaks
Is this a new competitive opportunity or a continuation?
This is a continuation funding opportunity (OpportunityCategory: Continuation). It is intended to extend or build on an existing CDC-funded effort rather than launching a new competitive program.
What is the funding opportunity number?
The funding opportunity number is CDC RFA GH14 140103CONT16.
What is the CFDA number associated with this opportunity?
The opportunity is associated with CFDA 93.185, which indicates it falls under CDC global health or immunization-related assistance.
What activity category is this opportunity listed under?
It is positioned within the health activity category.
When was this opportunity posted?
The opportunity was created and posted on October 28, 2015.
What is the application deadline?
The original and current closing date listed is December 29, 2015.
Does the listing state an award ceiling (maximum award amount)?
The listing notes an award ceiling of 0.
Why might the award ceiling be listed as 0?
The provided description indicates this can occur in continuation notices when funding levels are determined by existing cooperative agreement terms, prior year funding, negotiated work plans, or the availability of appropriations, rather than a stated maximum intended for new applicants.
Does the listing specify the expected number of awards?
The expected number of awards is not specified in the provided information.
Who is eligible to apply?
Eligibility is listed as "Others", with a reference to consult an "Additional Information on Eligibility" section for precise details. The excerpt provided does not include that clarifying text.
Is eligibility likely broad or restricted?
Based on the continuation nature of the opportunity and the use of the "Others" category (with details located in a separate eligibility section not included here), the safest interpretation from the provided information is that eligibility is restricted and not broadly open to all applicant types.
What types of entities might be included under "Others" (based on the description provided)?
The description notes that this phrasing is commonly used when eligibility is limited to specific entities, such as:
- An existing award recipient
- A narrow set of organizations with a particular role
- Partners meeting specific criteria not captured by standard categories (for example, certain nonprofit organizations, international organizations, or entities already engaged in a defined immunization partnership)
The excerpt does not provide the definitive eligibility list.
What is the overall goal of the program as described?
The overall goal is to support countries or regional partners in the Americas in maintaining elimination gains against polio, rubella, and measles by strengthening immunization program performance and supporting public health infrastructure.
What program capacities are emphasized as important to prevent resurgence?
The description emphasizes capacities such as strong routine immunization performance, high coverage, reliable surveillance, rapid outbreak response, better data quality and use, operational improvements, and readiness to detect and respond quickly so elimination achievements are not reversed.
What makes this opportunity different from a typical grant with minimal federal involvement?
Because it is a cooperative agreement, CDC is expected to have substantial involvement in the work (for example, collaboration on planning, technical guidance, monitoring, and performance evaluation) rather than simply providing funds.
Browse more opportunities from the same category: Health
Next opportunity: USAID Regional Health Integration to Enhance Services in East Central Uganda (USAID RHITES EC)
Previous opportunity: Digital Humanities Implementation Grants
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA GH14 140103CONT16
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA GH14 140103CONT16) also looked into and applied for these:
| Funding Opportunity |
|---|
| USAID Regional Health Integration to Enhance Services in East Central Uganda (USAID RHITES EC) Apply for RFA 617 16 000001 Funding Number: RFA 617 16 000001 Agency: USAID-UGA Category: Health Funding Amount: $57,000,000 |
| Technical Assistance in Support of HIV Prevention, Care, and Treatment Programs and Other Infectious Diseases that Impact HIV Infected Patients in Support of the President's Emergency Plan for AIDS Relief Apply for CDC RFA PS09 904SUPP Funding Number: CDC RFA PS09 904SUPP Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Rural Health Network Development Planning Program Apply for HRSA 16 017 Funding Number: HRSA 16 017 Agency: HHS-HRSA Category: Health Funding Amount: Case Dependent |
| MCH Navigator Program Apply for HRSA 16 043 Funding Number: HRSA 16 043 Agency: HHS-HRSA Category: Health Funding Amount: Case Dependent |
| Supporting and Maintaining the Surveillance System for Chronic Kidney Disease in the United States Apply for CDC RFA DP16 1604 Funding Number: CDC RFA DP16 1604 Agency: HHS-CDC-NCCDPHP Category: Health Funding Amount: $700,000 |
| Local Non-governmental Partnerships for Sustained Country Leadership in Uganda under the President’s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH14 141202CONT16 Funding Number: CDC RFA GH14 141202CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Development and Translation of Medical Technologies to Reduce Health Disparities (SBIR) (R43/R44) Apply for RFA EB 16 001 Funding Number: RFA EB 16 001 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| Integrated HIV Prevention Program for the Federal Police Force of Ethiopia Under the President's Emergency Plan for AIDS Relief Apply for CDC RFA PS10 10110SUPP Funding Number: CDC RFA PS10 10110SUPP Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| COMPREHENSIVE PLATFORM FOR INTEGRATED COMMUNICATIONS INITIATIVE (CPICI) Apply for RFI 621 16 00002 Funding Number: RFI 621 16 00002 Agency: USAID-TAN Category: Health Funding Amount: $46,200,000 |
| NIDCD Early Career Research (ECR) Award (R21) Apply for PAR 16 057 Funding Number: PAR 16 057 Agency: HHS-NIH11 Category: Health Funding Amount: $100,000 |
| Tropical Medicine Research Centers (U19) Apply for RFA AI 16 002 Funding Number: RFA AI 16 002 Agency: HHS-NIH11 Category: Health Funding Amount: $500,000 |
| Improving the Quality of HIV Service Delivery and Other Priority Public Health Interventions through Training Support for Epidemiology, Monitoring and Evaluation (M&E), Survey and Laboratory Services in Nigeria under the President’s Emergency Plan Apply for CDC RFA GH16 1642 Funding Number: CDC RFA GH16 1642 Agency: HHS-CDC-CGH Category: Health Funding Amount: $5,000,000 |
| National Institute on Aging Genetics of Alzheimer's Disease Data Storage Site (U24) Apply for PAR 16 047 Funding Number: PAR 16 047 Agency: HHS-NIH11 Category: Health Funding Amount: $1,000,000 |
| Implementation of One Health and Global Health Security Agenda in Viet Nam Apply for RFI 440 16 Funding Number: RFI 440 16 Agency: USAID-VIE Category: Health Funding Amount: $1,400,000 |
| Limited Competition - Stimulating Peripheral Activity to Relieve Conditions (SPARC): Comprehensive Functional Mapping of Neuroanatomy and Neurobiology of Organs (OT2) Apply for RFA RM 15 018 Funding Number: RFA RM 15 018 Agency: HHS-NIH11 Category: Health Funding Amount: $2,000,000 |
| Emergency Medical Services for Children Targeted Issues Program Apply for HRSA 16 053 Funding Number: HRSA 16 053 Agency: HHS-HRSA Category: Health Funding Amount: Case Dependent |
| Provision of Technical Assistance for Implementation of Comprehensive HIV Care, Treatment, and Support Programs in the United Republic of Tanzania through CDC under the President’s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH16 1648 Funding Number: CDC RFA GH16 1648 Agency: HHS-CDC-CGH Category: Health Funding Amount: $2,500,000 |
| HIV Vaccine and Biomedical Prevention Research Project Apply for SOL OAA 16 000026 Funding Number: SOL OAA 16 000026 Agency: USAID Category: Health Funding Amount: $160,000,000 |
| Metabolomics Data Analysis (R03) Apply for RFA RM 15 021 Funding Number: RFA RM 15 021 Agency: HHS-NIH11 Category: Health Funding Amount: $100,000 |
| Pre-application: Stimulating Peripheral Activity to Relieve Conditions (SPARC): Comprehensive Functional Mapping of Neuroanatomy and Neurobiology of Organs (OT1) Apply for RFA RM 15 003 Funding Number: RFA RM 15 003 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA GH14 140103CONT16", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.